IE
AXSM icon

Israel Englander’s Axsome Therapeutics AXSM Stock Holding History

Israel Englander’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-118,800
Closed -$10.1M – 5847
2024
Q4 		$10.1M Buy
118,800
+86,400
+267% +$7.95M ﹤0.01% 2173
2024
Q3 		$2.91M Buy
+32,400
New +$2.83M ﹤0.01% 3348
2024
Q2 		– Sell
-12,100
Closed -$966K – 5873
2024
Q1 		$966K Sell
12,100
-9,100
-43% -$764K ﹤0.01% 4324
2023
Q4 		$1.69M Buy
21,200
+17,200
+430% +$1.15M ﹤0.01% 3747
2023
Q3 		$280K Sell
4,000
-200
-5% -$15K ﹤0.01% 4968
2023
Q2 		$302K Buy
+4,200
New +$310K ﹤0.01% 4881
2021
Q4 		– Sell
-293,900
Closed -$9.69M – 6775
2021
Q3 		$9.69M Buy
+293,900
New +$11.5M 0.01% 2094
2021
Q2 		– Sell
-25,000
Closed -$1.42M – 6516
2021
Q1 		$1.42M Buy
25,000
+16,000
+178% +$1.13M ﹤0.01% 3854
2020
Q4 		$733K Buy
+9,000
New +$673K ﹤0.01% 3935
2020
Q1 		– Sell
-50,000
Closed -$5.17M – 3830
2019
Q4 		$5.17M Buy
+50,000
New +$2.02M 0.01% 1899
2019
Q2 		– Sell
-179,500
Closed -$2.55M – 4043
2019
Q1 		$2.55M Buy
+179,500
New +$1.67M ﹤0.01% 2246

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Israel Englander's AXSM Position: Q2 2026 in Review

Israel Englander increased its Axsome Therapeutics (AXSM) stake by 2,579% in Q2 2026, buying an estimated $116M and bringing the position to 556,088 shares worth $136M. The position accounts for 0.05% of the portfolio, ranked #381.

Israel Englander first reported a position in AXSM in Q4 2015 and has held it in 36 quarters since. 502 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Israel Englander held 556,088 shares of Axsome Therapeutics worth $136M as of Q2 2026.
  • Israel Englander bought 535,330 Axsome Therapeutics shares in Q2 2026, an estimated $116M.
  • Axsome Therapeutics made up 0.05% of Israel Englander's portfolio in Q2 2026, its #381 holding.
  • Israel Englander first reported a position in Axsome Therapeutics in Q4 2015 and has held it in 36 quarters since.
  • 502 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.